Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
94 studies found for:    Heart Block | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Reevaluation Of Systemic Early Neuromuscular Blockade
Condition: Acute Respiratory Distress Syndrome
Intervention: Drug: cisastracurium besylate
22 Recruiting Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention:
23 Recruiting Cardiometabolic Effects of Eplerenone in HIV Infection
Conditions: Cardiac Steatosis;   Hepatic Steatosis
Intervention: Drug: Inspra /Eplerenone
24 Recruiting Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
Conditions: Osteoarthritis;   Arthropathy;   Shoulder Pain;   Closed Fracture Proximal Humerus, Four Part
Interventions: Drug: Liposomal bupivacaine;   Drug: Interscalene Nerve Block
25 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
26 Recruiting Randomized Controlled Trial of Group Prevention Coaching
Condition: Cardiovascular Disease
Intervention: Behavioral: Problem Solving
27 Recruiting Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Condition: Healthy Subjects
Intervention:
28 Recruiting A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Conditions: Thymoma;   Thymic Carcinoma
Intervention: Drug: Avelumab
29 Recruiting Longitudinal Observational Study of Severe Asthma
Condition: Asthma
Intervention:
30 Recruiting Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Condition: Congenital Disorders of Glycosylation
Intervention:
31 Recruiting Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans
Conditions: Anxiety Disorder;   Fear
Interventions: Drug: SRX246;   Drug: Placebo
32 Recruiting Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
Conditions: Rhabdomyosarcoma;   Rhabdomyosarcoma- Alveolar;   Rhabdomyosarcoma-Embryonal
Interventions: Drug: Dasatinib;   Drug: Ganitumab
33 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368
34 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171
35 Recruiting Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Nilotinib + Paclitaxel
36 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
37 Recruiting A Novel Compound for Alcoholism Treatment: A Translational Strategy
Condition: Alcoholism
Interventions: Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
38 Not yet recruiting Deep Brain Stimulation Surgery for Focal Hand Dystonia
Conditions: Dystonia;   Focal Dystonia;   Musician's Dystonia
Intervention: Procedure: DBS surgery
39 Recruiting Study of Alkaptonuria
Condition: Alkaptonuria
Intervention:
40 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.